Takeda Pharmaceutical (TAK) Retained Earnings (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded Retained Earnings of $4.18 billion in the quarter ended Jun 30, 2026, down 47.7% from $7.99 billion a year earlier and down 7.9% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Retained Earnings (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical reported Retained Earnings of $4.73 billion, down 39.3% from the prior year.
- Annual Retained Earnings has declined for five straight years, with a five-year compound annual growth rate of -19.8% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Retained Earnings came in at $7.8 billion in the year ended Mar 31, 2025 (-19.2%), $9.65 billion in the year ended Mar 31, 2024 (-15.4%), $11.41 billion in the year ended Mar 31, 2023 (-13.4%) and $13.18 billion in the year ended Mar 31, 2022 (-7.5%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Retained Earnings in data going back to the quarter ended Mar 31, 2018.
- On a year-over-year basis, Retained Earnings has declined for three consecutive quarters, with an average decline of 23.3% over the last six quarters.
- The year-over-year decline in Retained Earnings has ranged between 3.7% (the quarter ended Jun 30, 2023) and 47.7% (the quarter ended Jun 30, 2026) over the last five years.
- Per Business Quant, the preceding three quarters came in at $4.54 billion (quarter ended Mar 31, 2026), $7.12 billion (quarter ended Dec 31, 2025) and $7.8 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 4.18 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.18 Bn |
| Mar 31, 2026 | 4.54 Bn |
| Dec 31, 2025 | 7.12 Bn |
| Sep 30, 2025 | 7.80 Bn |
| Jun 30, 2025 | 7.99 Bn |
| Mar 31, 2025 | 7.78 Bn |
| Dec 31, 2024 | 8.49 Bn |
| Jun 30, 2024 | 8.60 Bn |
| Mar 31, 2024 | 9.39 Bn |
| Dec 31, 2023 | 9.45 Bn |
| Sep 30, 2023 | 10.01 Bn |
| Jun 30, 2023 | 10.87 Bn |
| Mar 31, 2023 | 11.65 Bn |
| Dec 31, 2022 | 10.67 Bn |
| Sep 30, 2022 | 11.08 Bn |
| Jun 30, 2022 | 11.29 Bn |
| Mar 31, 2022 | 12.73 Bn |
| Jun 30, 2021 | 14.31 Bn |
| Mar 31, 2021 | 14.26 Bn |
| Dec 31, 2020 | 12.50 Bn |
API Access
Takeda Pharmaceutical Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();